TARAXACUM OFFICINALE; TRADITIONAL AND EXPERIMENTAL BIOLOGICAL ACTIVITIES

Yıl 2025, Cilt: 6 Sayı: 1, 37 - 60, 13.01.2025

Mehmet Erdem , Mehmet Özaslan

https://doi.org/10.55549/zbs.1564629

Öz

It is observed that Taraxacum officinale has been traditionally used for the treatment of various diseases for many years, and its use has also been identified clinically in disorders such as dyspepsia, liver, gallbladder, and urinary tract diseases.It is a plant with many bioactivities, especially strong anti-inflammatory, antioxidant, and hepatoprotective properties. When considering its side effects and toxicity, it is seen that there are no serious side effects or toxicity. In light of this information, it is evaluated that if brought into herbal medicine format due to its strong antioxidant, anti-inflammatory, anticancer, and hepatoprotective effects, it could be effective in the treatment of commonly seen diseases such as cancer, liver, and gallbladder diseases. According to the results of bioactivity studies conducted on the plant, Taraxacum officinale has been reported analgesic, antiallergic, antidepressant, anti-inflammatory, anti-hyperglycemic, anticarcinogenic, antimicrobial, antimutagenic, antioxidant, antispermic, antithrombotic, diuretic, hypolipidemic, immunological, choloretic, and prebiotic effects. Additionally, that it has hepatoprotective, nephroprotective, and neuroprotective properties. The acute toxicity of Taraxacum officinale seems to be low; when 95% ethanol extract of the whole plant was administered intraperitoneally in rats, the lethal dose was found to be 28.8 mg/kg. When 50% ethanol extract of the whole plant was administered intraperitoneally to rats, the maximum tolerable dose was found to be 500.0 mg/kg. No adverse or complex toxic effects have been reported for Taraxacum officinale. This literature review was prepared with the studies of articles on the Google Scholar and PubMed platforms. This review confirms the importance of phytotherapy studies for pharmacological purposes, aiming at therapeutic improvement.

Anahtar Kelimeler

Taraxacum officinale, antioxidant, anti-inflammatory, anticancer, in vivo, in vitro.

Kaynakça

• Astafieva AA, Rogozhin EA, Odintsova TI, Khadeeva NV, Grishin EV, Egorov TA. (2012). Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers. Peptides, 36(2), 266-271.
• Astafieva AA, Rogozhin EA, Andreev YA, Odintsova TI, Kozlov SA, Grishin EV, Egorov TA. (2013). A novel cysteine-rich antifungal peptide ToAMP4 from Taraxacum officinale Wigg. flowers. Plant Physiology Biochemistry, 70,93-99.
• Astafieva AA, Enyenihi AA, Rogozhin EA, Kozlov SA, Grishin EV, Odintsova TI, Zubarev RA, Egorov TA. (2015). Novelproline-hydroxyproline glycopeptides from the dandelion (Taraxacum officinale Wigg.) flowers: de novo sequencing and biological activity. Plant Science, 238, 323-329.
• Awortwe C, Sackeyfio AC, Osei-Safo D, Bugyei KA, Asiedu-Gyekye IJ. (2011). Dual effect of Taraxacum officinale leaves: Anticholinergic and inhibitory effect on inflammatory cells in ovalbumin-sensitized guinea-pigs. Afrıcan Journal of Pharmacy and Pharmacology, 5(23), 2613-2619.
• Baba, K., Abe, S., & Mizuno, D. (1981). Antitumor activity of hot water extract of dandelion, Taraxacum officinale-correlation between antitumor activity and timing of administration (author's transl). Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan, 101(6), 538-543.
• Baytop T. (1999). Türkiye’de Bitkilerle Tedavi. (2.Baskı). İstanbul: Nobel Kitabevi, 227- 228.
• Causey, J. L., Feirtag, J. M., Gallaher, D. D., Tungland, B. C., & Slavin, J. L. (2000). Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutrition Research, 20(2), 191-201.
• Chakŭrski, I., Matev, M., Koĭchev, A., Angelova, I., & Stefanov, G. (1981). Treatment of chronic colitis with an herbal combination of Taraxacum officinale, Hipericum perforatum, Melissa officinaliss, Calendula officinalis and Foeniculum vulgare. Vutreshni bolesti, 20(6), 51-54.
• Chatterjee, S. J., Ovadje, P., Mousa, M., Hamm, C., & Pandey, S. (2010). The efficacy of dandelion root extract in inducing apoptosis in drug-resistant human melanoma cells. Evidence-Based Complementary and Alternative Medicine, 2011.
• Cho, S. Y., Oh, Y. J., Park, J. Y., Lee, M. K., & Kim, M. J. (2003). Effect of dandelion (Taraxacum officinale) leaf extracts on hepatic antioxidative system in rats fed high cholesterol diet. Journal of the Korean Society of Food Science and Nutrition, 32(3).
• Choi EJ, Kim GH. (2009). Dandelion (Taraxacum officinale) flower ethanol extract inhibits cell proliferation and induces apoptosis in human ovarian cancer SK-OV-3 cells. Food Scıence and Bıotechnology, 18(2), 552-555.
• Choi UK, Lee OH, Yim JH, Cho CW, Rhee YK, Lim SI, Kim YC. (2010). Hypolipidemic and antioxidant effects of dandelion (Taraxacum officinale) root and leaf on cholesterol-fed rabbits. InternatıonalJ ournal of Molecular Scıences, 11(1), 67-78.
• Clare BA, Conroy RS, Spelman, K. (2009). The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. Journal of Alternative and Complementary Medicine, 15(8), 929-934.
• Colle D, Arantes LP, Gubert P, da Luz SC, Athayde ML, Teixeira Rocha JB, Soares FA. (2012a). Antioxidant properties of Taraxacum officinale leaf extract are involved in the protective effect against the patoxicity induced by Acetaminophen in mice. Journal of Med icinal Food, 15(6):549-556.
• Colle D, Arantes LP, Rauber R, de Mattos SEC, da Rocha JBT, Nogueira CW, Soares, FA. (2012b). Antioxidant properties of Taraxacum officinale fruit extract are involved in the protective effect against cellular death induced by sodium nitroprusside in brain of rats. Pharmaceutıcal Biology, 50(7), 883-891.
• Didier, F., Catherine, F., Odile, T., & Jean-Louis, L. (2011). Caffeoyl derivatives: major antioxidant compounds of some wild herbs of the Asteraceae family. Food and Nutrition Sciences, 2011.
• Di Giorgio C, Boyer L, De Meo M, Laurant C, Elias R, Ollivier E. (2015).In vitro and in vivo antimutagenic effects of DIG, a herbal preparation of Berberisvulgaris, Taraxacum officinale and Arctium lappa, against mitomycin C. Journal of Natural Medıcınes, 69(3), 267-277.
• Domitrović R, Jakovac H, Romić Z, Rahelić D, Tadić Z. (2010). Antifibrotic activity of Taraxacum officinale root in carbontetrachloride-induced liver damage in mice. Journal of Ethnopharmacol, 130(3), 569-577.
• ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products. (2003). (2.Edition). Stuttgard:Thieme, 499-502.
• Gargouri M, Ghorbel-Koubaa F, Bonenfant-Magné M, Magné C, Dauvergne X, Ksouri R, Krichen Y, Abdelly C, El Feki A (2012) Spirulina or dandelion-enriched diet of mothers alleviates lead-induced damages in brain and cerebellum of newborn rats. Food Chem Toxicol 50(7):2303–2310
• Gonzalez-Castejon M, Garcia-Carrasco B, Fernandez-Dacosta R, Davalos A, Rodriguez- Casado A. (2014). Reduction of adipogenesis and lipid accumulation by Taraxacum officinale (dandelion) extracts in 3T3L1 adipocytes: an in vitro study. Phytotherapy Research,28(5), 745-752.
• Grases F, Melero G, Costa-Bauzá A, Prieto R, March JG (1994) Urolithiasis and phytotherapy. Int Urol Nephrol 26(5):507–511
• Greenlee H, Atkinson C, Stanczyk FZ, Lampe JW (2007) A pilot and feasibility study on the effects of naturopathic botanical and dietary interventions on sex steroid hormone metabolism in premeno- pausal women. Cancer Epidemiol Biomarkers Prev 16(8):1601–1609
• Gulfrazl M, Ahamd D , Ahmad MS, Qureshi R, Mahmood RT, Jabeen N, Abbasi KS. (2014). Effect of leaf extracts of Taraxacum officinale on CCl4 induced hepatotoxicity in rats, in vivo study. Pakıstan Journal of Pharmaceutıcal Scıences, 27(4), 825-829.
• Han H, He W, Wang W, Gao B (2011) Inhibitory effect of aqueous dandelion extract on HIV-1 replication and reverse transcriptase activity. BMC Complement Altern Med 11:112
• Hata, K., Ishikawa, K., Hori, K., & KONISHI, T. (2000). Differentiation-inducing activity of lupeol, a lupane-type triterpene from Chinese dandelion root (Hokouei-kon), on a mouse melanoma cell line. Biological and Pharmaceutical Bulletin, 23(8), 962-967.
• Hata, K., Mukaiyama, T., Tsujimura, N., Sato, Y., Kosaka, Y., Sakamoto, K., & Hori, K. (2006). Differentiation-inducing activity of lupane triterpenes on a mouse melanoma cell line. Cytotechnology, 52(3), 151-158.
• Hfaiedh M, Brahmi D, Zourgui L. (2016). Hepatoprotective effect of Taraxacum officinale leaf extract on sodium dichromate-induced liver injury in rats. Envıronmental Toxıcology, 31(3), 339-349.
• Hu, C., & Kitts, D. D. (2003). Antioxidant, prooxidant, and cytotoxic activities of solvent-fractionated dandelion (Taraxacum officinale) flower extracts in vitro. Journal of agricultural and food chemistry, 51(1), 301-310. Hu, C., & Kitts, D. D. (2004). Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264. 7 cells. Molecular and cellular biochemistry, 265, 107-113.
• Hu, C., & Kitts, D. D. (2005). Dandelion (Taraxacum officinale) flower extract suppresses both reactive oxygen species and nitric oxide and prevents lipid oxidation in vitro. Phytomedicine, 12(8), 588-597.
• Jackson, L. N., Zhou, Y., Qiu, S., Wang, Q., & Mark Evers, B. (2008). Alternative medicine products as a novel treatment strategy for inflammatory bowel disease. The American journal of Chinese medicine, 36(05), 953-965.
• Jeon, H. J., Kang, H. J., Jung, H. J., Kang, Y. S., Lim, C. J., Kim, Y. M., & Park, E. H. (2008). Anti-inflammatory activity of Taraxacum officinale. Journal of ethnopharmacology, 115(1), 82-88.
• Jinchun Z, Jie C. (2011). The effects of Taraxacum officinale extracts (TOE) supplementation on physical fatigue in mice. The African Journal of Traditional, Complementary and Alternative medicines , 8(2):128-33.
• Kashiwada, Y., Takanaka, K., Tsukada, H., Miwa, Y., Taga, T., Tanaka, S., & Ikeshiro, Y. (2001). Sesquiterpene glucosides from anti-leukotriene B4 release fraction of Taraxacum officinale. Journal of Asian Natural Products Research, 3(3), 191-197.
• Kenny O, Smyth TJ, Hewage CM, Brunton NP. (2015). Quantitative UPLC-MS/MS analysis of chlorogenic acid derivatives in antioxidant fractionates from dandelion (Taraxacum officinale) root .Internatıonal Journal of Food Scıence and Technology, 50(3), 766-773.
• Kekre N, Griffin C, McNulty J.P Siyaram ( 2005). Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidylserine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother Pharmacol. 56:29–38.
• Kim JJ, Park CM, Kim MJ, Cho CW, Song YS. (2014). Hypolipidemic effect of dandelion (Taraxacum officinale) extracts via fecal lipid excretion in C57BL/6 mice fed an atherogenic diet. Food Scıence and Bıotechnology, 23(3), 841-847.
• Koh YJ, Cha DS, Ko JS, Park HJ, Choi HD. (2010). Anti-ınflammatoryeffect of Taraxacum officinale leaves on lipopolysaccharide-ınduced ınflammatory responses in RAW 264.7 cells. Journal of Medıcınal Food, 13(4), 870-878.
• Koo, H. N., Hong, S. H., Song, B. K., Kim, C. H., Yoo, Y. H., & Kim, H. M. (2004). Taraxacum officinale induces cytotoxicity through TNF-α and IL-1α secretion in Hep G2 cells. Life Sciences, 74(9), 1149-1157.
• Kuusi, T., Pyysalo, H., & Autio, K. (1985). The bitterness properties of dandelion. II. Chemical investigations. Lebensmittel-Wissenschaft+ Technologie, 18(6), 347-349.
• Lee, J. P., Li, Y. C., Chen, H. Y., Lin, R. H., Huang, S. S., Chen, H. L., ... & Kuan, Y. H. (2010). Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils. Acta Pharmacologica Sinica, 31(7), 831-838.
• Lee, B. R., Lee, J. H., & An, H. J. (2012). Effects of Taraxacum officinale on fatigue and immunological parameters in mice. Molecules, 17(11), 13253-13265.
• Li YC, Shen JD, Li YY, Huang Q. (2014). Antidepressant effects of the water extract from Taraxacum officinale leaves and roots in mice. Pharmaceutical Biology,52 (8), 1028-1032.
• Liu L, Xiong H, Ping J. (2010) Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice. J Ethnopharmacol.130:392–397.
• Ma, P., Dong, X., Swadley, C. L., Gupte, A., Leggas, M., Ledebur, H. C., & Mumper, R. J. (2009). Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. Journal of biomedical nanotechnology, 5(2), 151-161.
• Mahesh, A., Jeyachandran, R., Cindrella, L., Thangadurai, D., Veerapur, V., & Muralidhara Rao, D. (2010). Hepatocurative potential of sesquiterpene lactones of Taraxacum officinale on carbon tetrachloride induced liver toxicity in mice. Acta Biologica Hungarica, 61(2), 175-190.
• Maliakal, P. P., & Wanwimolruk, S. (2001). Effect of herbal teas on hepatic drug metabolizing enzymes in rats. Journal of Pharmacy and Pharmacology, 53(10), 1323-1329.
• Martinez M, Poirrier P, Chamy R, Prufer D, Schulze-Gronover C, Jorquera L, Ruiz G. (2015). Taraxacum officinale and related species-an ethnopharmacological review and its potential as a commercial medicinal plant. Journal of Ethnopharmacology, 169, 244-262.
• Modaresi, M., & Resalatpour, N. (2012). The effect of Taraxacum officinale hydroalcoholic extract on blood cells in mice. Advances in hematology, 2012.
• Munoz Mingarro D, Plaza A, Galan A,Vicente JA, Martinez MP, Acero N. (2015). The effect of five Taraxacum species on in vitro and in vivo antioxidant and antiproliferative activity. Food and Function, 6(8), 2787-2793.
• Neef, H., Cilli, F., Declerck, P. J., & Laekeman, G. (1996). Platelet anti-aggregating activity of Taraxacum officinale Weber. Phytotherapy Research, 10(SUPPL. 1).
• Odintsova TI, Rogozhin EA, Sklyar IV, Musolyamov AK, Kudryavtsev AM , Pukhalsky, VA, Smirnov, AN, Grishin, EV , Egorov, TA. (2010). Antifungal Activity of Storage 2S Albumins from Seeds of the Invasive Weed Dandelion Taraxacum officinale Wigg. Protein and Peptide Letters,17(4), 522-529.
• Ovadje P, Chatterjee S, Griffin C, Tran C, Hamm C, Pandey S. (2011). Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol 133(1): 86–91
• Ovesna, Z., Vachalkova, A., Horvathova, K., & Tothova, D. (2004). Pentacyclic triterpenoic acids: new chemoprotective compounds Minireview. Neoplasma, 51(5), 327-333.
• Park CM, Jin KS, Lee YW, Song YS. (2011). Luteolin and chicoric acid synergistically inhibited inflammatory responses via in activation of PI3K-Akt pathway and impairment of NF kappa B translocation in Lps stimulated RAW 264.7 cells. European Journal of Pharmacology, 660(2-3), 454-459.
• Park CM, Park JY, Noh KH, Shin JH, Song YS. (2011a).Taraxacum officinale Weber extracts inhibit Lps-induced oxidative stres and nitric oxide production via the NF kappa B modulation in RAW 264.7 cells. Journal of Ethnopharmacology, 133(2), 834-842.
• Park CM, Cho CW, Song YS. (2014). Top 1 and 2, polysaccharides from Taraxacum officinale, inhibit NF kappa B-mediated inflammation and accelerate Nrf2-induced antioxidative potential through the modulation of PI3K-Akt signaling pathway in RAW 264.7cells. Food and Chemıcal Toxıcology ,66,56-64.
• Park CM, Youn HJ, Chang, HK,Song YS. (2010). TOP 1 and 2 polysaccharides from Taraxacum officinale, attenuate CCl4-induced hepatic damage through the modulation of NF kappa B and its regulatory mediators. Food and Chemıcal Toxıcology,48 (5), 1255-1261.
• Piao, T., Ma, Z., Li, X., & Liu, J. (2015). Taraxasterol inhibits IL-1β-induced inflammatory response in human osteoarthritic chondrocytes. European Journal of Pharmacology, 756, 38-42.
• PDR for Herbal Medicines. (2008). (2.Edition). Montvale, New Jersey, 252-254.
• Râcz–Kotilla, E., Racz, G., & Solomon, A. (1974). The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta medica, 26(07), 212-217.
• Rehman S, Ijaz B, Fatima N, Muhammad SA, Riazuddin S. (2016). Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: in-vitro and in silico study. Biomedicine and Pharmacotherapy, 83,81-891.
• Risau, W. (1995). Differentiation of endothelium. The FASEB journal, 9(10), 926-933.
• Roberts, P. J., & Der, C. J. (2007). Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene, 26(22), 3291-3310.
• Saeki, D., Yamada, T., In, Y., Kajimoto, T., Tanaka, R., Iizuka, Y., ... & Masuda, K. (2013). Officinatrione: an unusual (17S)-17, 18-seco-lupane skeleton, and four novel lupane-type triterpenoids from the roots of Taraxacum officinale. Tetrahedron, 69(5), 1583-1589.
• Schütz K, Carle R, Schieber A. (2006). Taraxacum--a review on its phytochemical and pharmacological profile. Journal of Ethnopharmacology,107(3), 313-323.
• Sigstedt, S. C., Hooten, C. J., Callewaert, M. C., Jenkins, A. R., Romero, A. E., Pullin, M. J., ... & Steelant, W. F. (2008). Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. International journal of oncology, 32(5), 1085-1090.
• Seo SW, Koo HN, An HJ. (2005). Taraxacum officinale protects against cholecystokinin-induced acute pancreatitis in rats. World J Gastroenterol.11:597–599.
• Soest J. L. Van, (1975).Taraxacum Wiggers. Davis PH.(Edıtor). Flora of Turkey and the East Aegean Islands. Univeristy press: Edinburgh Vol. 5, 788-812.
• Tahtamouni LH, Alqurna NM, Al-Hudhud MY, Al-Hajj HA. (2011). Dandelion (Taraxacum officinale) decreases malerat fertility in vivo. Journal of Ethnopharmacol, 135(1), 102-109.
• Tahtamouni LH, Al-Khateeb RA, Abdellatif RN, Al-Mazaydeh ZA, Yasin SR, Al- Gharabli S, Elkarmi AZ. (2016). Anti-spermatogenic activities of Taraxacum officinale whole plant and leaves aqueous extracts. Veterinary Research
• Takasaki, M., Konoshima, T., TOKUDA, K., Masuda, K., Arai, Y., SHIOJIMA, K., & AGETA, H. (1999). Anti-carcinogenic activity of Taraxacum plant. II. Biological and Pharmaceutical Bulletin, 22(6), 602-610.
• Tong, Y., Zhang, X., Zhao, W., Zhang, Y., Lang, J., Shi, Y., ... & Ding, J. (2004). Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis. European journal of pharmacology, 494(2-3), 101-109.
• Vogel G (1977) Natural substances with effects on the liver. In: Wagner H, Wolff P (eds) New natural products and plant drugs with pharmacological, biological or therapeutic activity. Springer, Heidelberg
• WHO Monographs on Selected Medicinal Plants. (2007). Spain,volume 3, 328-338.
• Williams, C. A., Goldstone, F., & Greenham, J. (1996). Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale. Phytochemistry, 42(1), 121-127.
• Wynn, T. A. (2007). Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. The Journal of clinical investigation, 117(3), 524-529.
• Yang YF, Li SS. (2015). Dandelion extracts protect human skin fibroblasts from UVB damage and cellular senescence. Oxıdatıve Medıcıne and Cellular Longevıty, 619560.
• Zhang J, Kang MJ, Kim MJ, Kim ME, Song JH, Lee YM, Kim JI. (2008). Pancreatic lipase inhibitory activity of Taraxacum officinale in vitro and in vivo. Nutrition Research and practice, 2(4), 200-203.
• Zhang X, Xiong H, Liu L. (2012). Effects of taraxasterol on inflammatory responses in lipopolysaccharide-induced RAW 264.7 macrophages. Journal of Ethnopharmacol,141(1), 206-211.
• Zhi, X., Honda, K. I., Ozaki, K., Misugi, T., Sumi, T., & Ishiko, O. (2007). Dandelion T-1 extract up-regulates reproductive hormone receptor expression in mice. International Journal of Molecular Medicine, 20(3), 287-292.